Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Concentration Atropine Eye Drops for Delaying Myopia Progression in Children
ChiCTR2600118671Phase 4Recruiting
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Feb 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in myopia (2 arms), sponsored by Eye Hospital of Wenzhou Medical University. Primary endpoint: Equivalent spherical power after cycloplegic refraction at Week 48. Started Feb 2026; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2600118671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118671.